biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Volume

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Dec 16, 2022 4:47pm

121 Views

Post# 35176884

RE:Volume

To the "Volume" post we might add that the closing price of BTI was 6¢.

MTP closed at a flat 80¢ after a low today of a flat 70¢ - down 59% this week.

And pof and craig want to argue with all of the investors who traded a combined near one million shares today.and drove the prices down like this.

Tough argument to win, boys. You're a couple of regular don quixotes. Well, maybe only don quix.

jd

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments